Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

308 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Peginterferon alpha-2b plus ribavirin for treatment of chronic hepatitis C with severe fibrosis: a multicentre randomized controlled trial comparing two doses of peginterferon alpha-2b.
Abergel A, Hezode C, Leroy V, Barange K, Bronowicki JP, Tran A, Alric L, Castera L, Bernard PH, Henquell C, Lafeuille H, Ughetto S, Darcha C, Chevallier M, Martineau N, Dubost S, Randl K, Dhumeaux D, Bommelaer G, Bonny C; French multicenter study group. Abergel A, et al. J Viral Hepat. 2006 Dec;13(12):811-20. doi: 10.1111/j.1365-2893.2006.00768.x. J Viral Hepat. 2006. PMID: 17109680 Clinical Trial.
[Interactions between chronic viral hepatitis C and pregnancy].
Grangé JD, Abergel A, Amiot X, Chaslin-Ferbus D, Aygalenq P, Fouqueray B, Valla D, Bommelaer G, Bodin F. Grangé JD, et al. Among authors: abergel a. Gastroenterol Clin Biol. 1995 May;19(5):520-4. Gastroenterol Clin Biol. 1995. PMID: 7590005 Review. French.
[Mixed cryoglobulins and autoimmunity in hepatitis C].
Tridon A, Abergel A, Kuder P, Henquell C, Malaure H, Dibet P, Ghrib J, Bommelaer G, Bétail G. Tridon A, et al. Among authors: abergel a. Pathol Biol (Paris). 1997 Apr;45(4):291-7. Pathol Biol (Paris). 1997. PMID: 9296077 French.
Tenoxicam, a non-steroid anti-inflammatory drug, is unable to increase the response rate in patients with chronic hepatitis C treated by alpha interferon.
Zarski JP, Maynard-Muet M, Chousterman S, Baud M, Barnoud R, Abergel A, Bacq Y, Combis JM, Causse X, Tran A, Oberti F, Minello A, Bresson-Hadni S, Bailly F, Raabe JJ, Leroy V, Hamici L, Hicham T, Girardin MF. Zarski JP, et al. Among authors: abergel a. Hepatology. 1998 Mar;27(3):862-7. doi: 10.1002/hep.510270332. Hepatology. 1998. PMID: 9500719 Clinical Trial.
[Sarcoidosis gastropathy: diagnosis and contribution of echo-endoscopy].
Marcato N, Abergel A, Froment S, Collin C, Kuder P, Darcha C, Dapoigny M, de Laguillaumie B, Bommelaer G. Marcato N, et al. Among authors: abergel a. Gastroenterol Clin Biol. 1999 Mar;23(3):394-7. Gastroenterol Clin Biol. 1999. PMID: 10384345 Free article. French.
A randomized trial of ribavirin and interferon-alpha vs. interferon-alpha alone in patients with chronic hepatitis C who were non-responders to a previous treatment. Multicenter Study Group under the coordination of the Necker Hospital, Paris, France.
Pol S, Couzigou P, Bourlière M, Abergel A, Combis JM, Larrey D, Tran A, Moussalli J, Poupon R, Berthelot P, Bréchot C. Pol S, et al. Among authors: abergel a. J Hepatol. 1999 Jul;31(1):1-7. doi: 10.1016/s0168-8278(99)80157-3. J Hepatol. 1999. PMID: 10424277 Clinical Trial.
308 results